(Q28368762)

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

5-HT1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

Low-dose clozapine improves dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

Clozapine. A novel antipsychotic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Schizophrenia. Charting the circuits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Behavioural effects of serotonin agonists and antagonists in the rat and marmoset.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

[125I]BE 2254, a new high affinity radioligand for α1-adrenoceptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

The emerging role of clozapine in the treatment of movement disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Behavioral effects of clozapine and dopamine receptor subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Cataleptogenic effect of subtype selective 5-HT receptor antagonists in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

5-HT2 antagonism and EPS benefits: is there a causal connection?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Differential expression of two alpha 2-adrenergic receptor subtype mRNAs in human tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Role of dopamine D2, D4 and serotonin(2A) receptors in antipsychotic and anticataleptic action.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

A re-investigation of questionable subclassifications of presynaptic alpha2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021

Startle and sensorimotor correlates of ventral thalamic dopamine and GABA in rodents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701975

7 January 2021